デ・ウエスタン・セラピテクス研究所 普通株式
Id | Date_of_disclosure | Date_of_calculation | Code_of_stock | Name_of_stock_jp | Name_of_stock_en | Name_of_short_seller | Address_of_short_seller | Name_of_discretionary_investment_contractor | Address_of_discretionary_investment_contractor | Name_of_investment_fund | Ratio_of_short_positions_to_shares_outstanding | Number_of_short_positions_in_shares | Number_of_short_positions_in_trading_units | Date_of_calculation_in_previous_reporting | Ratio_of_short_positions_in_previous_reporting | Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 176365 | 2024-04-19 | 2024-04-17 | 4576 | デ・ウエスタン・セラピテクス研究所 普通株式 | D.Western Therapeutics Institute, Inc. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.0052 | 167400 | 1674 | 2024-04-16 | 0.0044 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |
| 174708 | 2024-04-23 | 2024-04-19 | 4576 | デ・ウエスタン・セラピテクス研究所 普通株式 | D.Western Therapeutics Institute, Inc. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.0064 | 206700 | 2067 | 2024-04-17 | 0.0052 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |
| 174709 | 2024-04-23 | 2024-04-19 | 4576 | デ・ウエスタン・セラピテクス研究所 普通株式 | D.Western Therapeutics Institute, Inc. | MERRILL LYNCH INTERNATIONAL | 2 KING EDWARD STREET, LONDON, EC1A 1HQ | nan | nan | nan | 0.0052 | 168100 | 1681 | 2024-04-18 | 0.0048 | nan |
| 173901 | 2024-04-24 | 2024-04-22 | 4576 | デ・ウエスタン・セラピテクス研究所 普通株式 | D.Western Therapeutics Institute, Inc. | MERRILL LYNCH INTERNATIONAL | 2 KING EDWARD STREET, LONDON, EC1A 1HQ | nan | nan | nan | 0.005 | 163200 | 1632 | 2024-04-19 | 0.0052 | nan |
| 172401 | 2024-04-26 | 2024-04-24 | 4576 | デ・ウエスタン・セラピテクス研究所 普通株式 | D.Western Therapeutics Institute, Inc. | MERRILL LYNCH INTERNATIONAL | 2 KING EDWARD STREET, LONDON, EC1A 1HQ | nan | nan | nan | 0.0036 | 117000 | 1170 | 2024-04-22 | 0.005 | nan |
| 131967 | 2024-05-02 | 2024-04-30 | 4576 | デ・ウエスタン・セラピテクス研究所 普通株式 | D.Western Therapeutics Institute, Inc. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.0070999999999999995 | 228200 | 2282 | 2024-04-19 | 0.0064 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |
| 128162 | 2024-05-13 | 2024-05-09 | 4576 | デ・ウエスタン・セラピテクス研究所 普通株式 | D.Western Therapeutics Institute, Inc. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.0069 | 225000 | 2250 | 2024-04-30 | 0.0070999999999999995 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |
| 121301 | 2024-05-23 | 2024-05-21 | 4576 | デ・ウエスタン・セラピテクス研究所 普通株式 | D.Western Therapeutics Institute, Inc. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.006999999999999999 | 227800 | 2278 | 2024-05-09 | 0.0069 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |
| 119753 | 2024-05-27 | 2024-05-23 | 4576 | デ・ウエスタン・セラピテクス研究所 普通株式 | D.Western Therapeutics Institute, Inc. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.0085 | 276000 | 2760 | 2024-05-21 | 0.006999999999999999 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |
| 118995 | 2024-05-28 | 2024-05-24 | 4576 | デ・ウエスタン・セラピテクス研究所 普通株式 | D.Western Therapeutics Institute, Inc. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.0091 | 294400 | 2944 | 2024-05-23 | 0.0085 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |